Stockscreener 앱 받기
1.38
0.73%
0.010
전일 마감가:
$1.37
열려 있는:
$1.34
하루 거래량:
678.89K
Relative Volume:
1.40
시가총액:
$189.87M
수익:
-
순이익/손실:
$-45.44M
주가수익비율:
-3.7297
EPS:
-0.37
순현금흐름:
$-42.28M
1주 성능:
-5.48%
1개월 성능:
+0.73%
6개월 성능:
+24.32%
1년 성능:
-13.21%
1일 변동 폭
$1.34
$1.465
1주일 범위
$1.33
$1.58
52주 변동 폭
$0.765
$2.34
Compass Therapeutics Inc Stock (CMPX) Company Profile
명칭
Compass Therapeutics Inc
전화
617-500-8099
주소
80 GUEST STREET, BOSTON
CMPX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
1.38 | 189.87M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | 개시 | Jefferies | Buy |
| 2023-01-27 | 개시 | Stifel | Buy |
| 2022-05-23 | 재개 | H.C. Wainwright | Buy |
| 2022-03-15 | 개시 | Ladenburg Thalmann | Buy |
| 2022-01-19 | 개시 | B. Riley Securities | Buy |
| 2021-12-22 | 개시 | Raymond James | Outperform |
| 2021-12-20 | 개시 | SVB Leerink | Outperform |
| 2021-12-15 | 개시 | Wedbush | Outperform |
모두보기
Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스
Biliary Tract Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News
Bioventus (NYSE:BVS) Upgraded to “Neutral” at JPMorgan Chase & Co. - Defense World
Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
Charles Schwab Investment Management Inc. Purchases New Stake in Ferrovial SE (NASDAQ:FER) - Defense World
The Manufacturers Life Insurance Company Purchases Shares of 13,221 Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World
Treatment Resistant Depression Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Charles Schwab Investment Management Inc. Purchases 9,268 Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World
The Manufacturers Life Insurance Company Invests $75,000 in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World
The Manufacturers Life Insurance Company Buys New Shares in Solid Biosciences Inc. (NASDAQ:SLDB) - Defense World
Charles Schwab Investment Management Inc. Grows Stock Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World
Layoff Tracker: Editas Will Cut 60% of Staff - BioSpace
Short Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Increases By 17.9% - MarketBeat
KalVista Appoints Jeb Ledell as Chief Operating Officer - citybiz
KalVista Pharmaceuticals Taps Former AVEO Oncology Executive as New COO in Strategic Leadership Move - StockTitan
Compass Therapeutics, Inc. Announces Executive Changes - Marketscreener.com
Sirius XM (NASDAQ:SIRI) Appoints Wayne D. Thorsen as Executive Vice President and COO - Defense World
Capstone Companies Reports Resignation of Directors and Appointment of New CEO - Defense World
Janus Henderson Group PLC Sells 3,373,056 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - MarketBeat
Reading International, Inc. Reports Results of 2024 Annual Meeting - Defense World
Greif, Inc. Revises 2024 Earnings Results Following Error Detection - Defense World
Plains All American Pipeline Reveals Plans for Investor Event and Updated Presentation Materials - Defense World
CONMED Corporation Declares Quarterly Cash Dividend - Defense World
MoneyLion Inc. Announces Merger Agreement with Gen Digital Inc. - Defense World
Compass Therapeutics names Barry Shin as new CFO By Investing.com - Investing.com Canada
Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year? - MSN
Is DXP Enterprises (DXPE) Stock Undervalued Right Now? - Yahoo Finance
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR
Compass (COMP) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance
Compass Therapeutics Appoints Barry Shin as Chief Financial Officer - citybiz
Compass Therapeutics names Barry Shin as new CFO - Investing.com India
Compass Therapeutics Appoints New CFO Amid Strategic Moves - TipRanks
Compass Therapeutics Names Barry Shin Chief Financial Officer - MarketWatch
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer - The Manila Times
Compass Therapeutics: Near-Term Readout, But Beware The High Stakes In Biliary Cancer - Seeking Alpha
Here is What to Know Beyond Why QUALCOMM Incorporated (QCOM) is a Trending Stock - Yahoo Finance
Why is Sociedad Química y Minera de Chile S.A. (SQM) Among the Best Lithium and Battery Stocks to Invest In? - Yahoo Finance
Ways employees can navigate toxic bosses - Yahoo Finance
Top US Penny Stocks To Watch In December 2024 - Yahoo Finance
SiriusXM to Present at the UBS Global Media and Communications Conference - Yahoo Finance
Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Compass Therapeutics to Present at Piper Sandler Healthcare Conference - StockTitan
Cancer Pain Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail
Celsius Holdings Inc. (CELH) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Major Depressive Disorder Market to Register Immense Growth by 2034 Owing to a Robust Pipeline | DelveInsight - The Malaysian Reserve
Down -23.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX) - Yahoo Canada Finance
PD-1 and PD-L1 Inhibitors Market Future Trends and Scope Analysis Report - openPR
FY2024 EPS Estimates for BCAX Cut by Cantor Fitzgerald - Defense World
Compass Therapeutics (NASDAQ:CMPX) Cut to Market Perform at Leerink Partners - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat
What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock - MSN
2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious - MSN
Compass Therapeutics Inc (CMPX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):